Based on types, the market has been segmented into serological testing, biopsy, and
others. The serological testing is sub-segmented into tissue transglutaminase (tTG)
antibody- IgA, serum and Tissue Transglutaminase (tTG) antibody-IgG, serum, and others.
Based on the end users, the market has been segmented as hospitals & clinics, homecare,
research organizations, and others.
Regional analysis
The Americas account for a significant market share owing to extensive use of medications
and high expenditure on the health care. Additionally, the fastest uptake of new technology
in the US drives the tTG testing market. Also, concentration of major research companies
and research organizations in the developed countries of this region add fuel to the market
growth.
Europe is the second largest market in the world due to high income and high healthcare
penetration.
Asia Pacific region is expected to grow rapidly over the forecast period and China and India
are likely to lead this market due to the fast growing healthcare sector.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East &
African market. The African region is expected to witness a moderate growth owing to poor
economic and political conditions and poor healthcare development during the review
period.
Table of Contents
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation